Navigation Links
Questcor Reports 2010 Financial Results
Date:2/23/2011

ANAHEIM, Calif., Feb. 23, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today reported financial results for the full year and fourth quarter ended December 31, 2010.

For the year ended December 31, 2010, net sales increased 30.4 percent to a record $115.1 million from $88.3 million in the prior year.  The Company's financial performance was driven by an increase in net sales for H.P. Acthar® Gel (Acthar), for the treatment of acute exacerbations of multiple sclerosis (MS).  Full year 2010 net income was $35.1 million, or $0.54 per diluted common share.  Net income for 2009 was $26.6 million, or $0.40 per diluted common share.

"Strong gains in MS prescriptions throughout 2010 drove record net sales for Acthar and Questcor," said Don M. Bailey, President and CEO of Questcor. "Our number one focus in 2010, as it will be again in 2011, was the growth of MS prescriptions for Acthar.  In the fourth quarter, we expanded our MS sales force for the fourth time. Each of the previous expansions resulted in significantly increased sales.  We expect MS sales to continue to grow in 2011."

"Also in the fourth quarter, the FDA approved our sNDA for infantile spasms (IS) and modernized the label for Acthar, so that the label now includes 19 approved indications. This development allowed us to begin promotion of Acthar in IS as well as for the on-label indications associated with nephrotic syndrome (NS)," added Mr. Bailey.

"Despite the disruption caused by doubling our sales force, new shipped MS Acthar prescriptions so far in the first quarter of 2011 are running slightly ahead of the pace in the fourth quarter and well ahead of the pace in the first quarter of 2010," continued Mr. Bailey.  "Also in the first quarter we are initiating an in-depth commercial exploration of the on-label opportunity for Acthar in NS.
'/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Questcor to Report Fourth Quarter and Full Year 2010 Earnings and Conduct Conference Call on February 23, 2011
2. Questcor Pharmaceuticals Reports Strong Finish to 2010
3. Questcor Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2011
4. Questcor Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
5. Questcor to Present at the Maxim Group Growth Conference
6. Questcor Reports Third Quarter 2010 Results
7. Questcor to Present at the 21st Annual Oppenheimer Healthcare Conference
8. Questcor Teams With Child Neurology Foundation (CNF) to Fund Infantile Spasms Scientific Research
9. Questcor and Child Neurology Foundation Support the 2nd Annual Infantile Spasms (IS) Awareness Week
10. Questcor to Present at UBS Global Life Sciences Conference
11. Mitchell J. Blutt, M.D. Appointed to Questcor Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)...  Results of the recent study, Results From ... Intra-Operative Positive Margin Detection , were presented as part ... Annual Miami Breast Cancer Conference last week. ... , MD, FACS, Professor of Surgery at the Sackler ... analysis of MarginProbe,s efficiency and accuracy when used consecutively ...
(Date:3/4/2015)... , March 4, 2015  Bayer HealthCare ... Administration (FDA) has accepted the company,s Biologics License ... VIII compound.  Bayer is seeking FDA approval of ... the treatment of hemophilia A in children and ... continually bringing new therapies to hemophilia A patients ...
(Date:3/4/2015)... -- Heska Corporation (Nasdaq: HSKA ) announces the ... Fourth Quarter and Year End 2014 Earnings Conference Call ... (MST) / 11:00 a.m. (EST)Where: www.heska.com (click on ... on the front page of this website)How:Live over the ... the address above.  Alternatively, you may use the following ...
Breaking Medicine Technology:New Study Shows Breast Re-excision Rates Significantly Reduced in 100 Consecutive Cases 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 3Webcast Alert: Heska Announces Fourth Quarter and Year End 2014 Earnings Conference Call Webcast 2
(Date:3/4/2015)... (PRWEB) March 04, 2015 Vancouver ... recently received two awards in the prestigious Vancouver ... on February 27, 2015. The company secured third ... place in the “Best Registered Massage Therapist” category. ... community newspapers in Canada, The Vancouver Courier is ...
(Date:3/4/2015)... The print component of “Organic Living” ... Chronicle with a circulation of approximately 173,000 copies and ... is distributed nationally through a vast social media strategy ... partner outlets. To explore the digital version of the ... composed of heat-dried microbes that have digested the organic ...
(Date:3/4/2015)... 2015 State officials have awarded $82,500 ... of Public Health at Georgia State University, to support ... by Georgia’s Division of Family and Children Services (DFCS) ... Call Center. , The 1-800-CHILDREN Helpline is a ... and referral services that promote the wellbeing of children ...
(Date:3/4/2015)... The Global Liquefied Petroleum Gas Market was ... estimated to grow to $288.7 billion by 2019, ... 2019. , Browse through the TOC of Global ... industry trends, segments & forecasts., http://www.micromarketmonitor.com/market-report/liquid-petroleum-gas-reports-5046983367.html ... is classified into source, application, and region. The ...
(Date:3/4/2015)... Diego, CA (PRWEB) March 04, 2015 ... the launch of their new L-Style Revolution™ Program. The ... for men and women of all health and fitness ... weight maintenance goals faster than traditional methods. , “We’re ... makes available customized plans based on award winning techniques ...
Breaking Medicine News(10 mins):Health News:Backs in Action Receives Two Awards in The Vancouver Courier Readers’ Choice Awards 2015 2Health News:State Funds Child Abuse Helpline Housed At Georgia State 2Health News:The Global Liquefied Petroleum Gas Market is Estimated to Reach $288.7 Billion by 2019 - A Report by MicroMarket Monitor 2Health News:The Global Liquefied Petroleum Gas Market is Estimated to Reach $288.7 Billion by 2019 - A Report by MicroMarket Monitor 3Health News:The Makers of Liporidex, The Popular Sports Nutrition Supplement Brand, Launches Its New L-Style Revolution™ Diet & Exercise Program That Promises Turbo Charged Results 2
... Safety council is offering free health and safety qualifications to its members, to 14 – 19 year olds and to those currently not in employment in a bid to increase awareness ... ... ... ...
... Findings could help spur change in how hypertension is ... --Following on recent, similar research, a large five-year study ... a key indicator of stroke risk. , In the ... 19,000 patients taking either beta blockers or calcium channel ...
... is one advance, ,Tommy John, elbow reconstruction another , SUNDAY, ... at the same time as anterior cruciate ligament (ACL) reconstruction ... , Meniscus cartilage acts as a cushion/shock absorber in the ... in the knee. , This study included 99 patients, 18 ...
... levels below currently recommended levels did not ... cardiovascular disease events in adults with type 2 diabetes ... events, according to new results from the landmark Action ... Similarly, treating multiple blood lipids with combination drug therapy ...
... ailment boosts odds for heart attack, stroke, and inflammation ... (HealthDay News) -- The common skin ailment psoriasis may ... cardiovascular woes, probably through a shared inflammatory response, a ... for psoriasis as a risk factor for cardiovascular disease," ...
... researchers say , SATURDAY, March 13 (HealthDay News) -- ... research shows that the performance of female marathoners can ... , Researchers analyzed marathon race results, weather data and ... a period of eight to 28 years. They found ...
Cached Medicine News:Health News:British Safety Council Offers Free Health and Safety Qualifications 2Health News:More Evidence That Swings in Blood Pressure Raise Stroke Risk 2Health News:Strides Seen in Orthopedic Surgery for Kids 2Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 2Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 3Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 4Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 5Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 6Health News:Psoriasis Tied to Raised Heart Risk 2Health News:Air Pollution Slows Women's Marathon Times 2
Creatinine Test Kit (enzymatic, liquid reagents), Wavelength: 550 nm. Linear range: up to 150 mg/dL....
For the quantitative determination of creatinine in serum. Fixed Time Reaction measured at 540 nm. Linearity: 25 mg/dl. Express Kit with Ready-to-Use Liquid....
Intended for the quantitative determination of magnesium in serum. Wavelength: 340 nm. Linearity: 9.7 mg/dL (4 mmol/L). Two vials, dry powder reagents....
Glucose reagent is used for the quantitative determination of glucose in human serum....
Medicine Products: